Eu Drug Regulator
- All
- News
- Videos
-
Weight-Loss Drugs Under EU Scanner Amid Suicide Risk Claims
The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.
-
EU Drug Regulator Backs New Monkeypox Jab Method To Stretch Vaccine Supply
The EU's drug regulator on Friday authorised a new technique for monkeypox injections that will allow up to five times more people to be innoculated as supplies of the vaccine run short.
-
EU Drug Watchdog Recommends Approving Use Of Smallpox Jab For Monkeypox
The European Union's drug watchdog on Friday recommended for approval the use of a smallpox vaccine to treat monkeypox, which could be classified by the World Health Organization as a global health emergency.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
Pfizer, Moderna Vaccines Safe During Pregnancy: EU Drug Regulator
Studies of pregnant women found the two most widely used Covid vaccines pose no risk to mothers or babies, the EU's drug regulator said on Tuesday.
-
Omicron Vaccine Could Get Approval In 3-4 Months: EU
Omicron Vaccine: Vaccines specially adapted for the new Omicron coronavirus variant could be approved in three to four months if they are needed, the head of the EU's drug regulator said on Tuesday.
-
EU Could Approve Vaccine Against New Covid Variant In 3 To 4 Months
The EU drug regulator said on Tuesday it could approve vaccines adapted to target the Omicron variant of the coronavirus within three to four months if needed, but that existing shots would continue to provide protection.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
European Union Approves Pfizer Covid Jab For 5 To 11-Year-Olds
The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.
-
EU Lists Rare Spinal Condition As Johnson & Johnson Vaccine Side Effect
Europe's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson's single-dose COVID-19 vaccine.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
EU Approval For Russia's Sputnik V Shot "Impossible This Year": Report
The EU drug regulator is unlikely to decide whether to approve Russia's Sputnik V coronavirus vaccine until at least the first quarter of 2022 because some data needed for the review is still missing, a source with knowledge of the matter said.
-
Switzerland Approves Second Covid Vaccine For Young People
Switzerland on Monday approved Moderna's Covid-19 vaccine for youngsters aged between 12 and 17 years old, weeks after EU regulators authorised the drug for the same age group.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
-
Weight-Loss Drugs Under EU Scanner Amid Suicide Risk Claims
The European Union's drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co. for more information as it reviews the potential risk of suicidal thoughts associated with a new class of weight-loss medicines.
-
EU Drug Regulator Backs New Monkeypox Jab Method To Stretch Vaccine Supply
The EU's drug regulator on Friday authorised a new technique for monkeypox injections that will allow up to five times more people to be innoculated as supplies of the vaccine run short.
-
EU Drug Watchdog Recommends Approving Use Of Smallpox Jab For Monkeypox
The European Union's drug watchdog on Friday recommended for approval the use of a smallpox vaccine to treat monkeypox, which could be classified by the World Health Organization as a global health emergency.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
Pfizer, Moderna Vaccines Safe During Pregnancy: EU Drug Regulator
Studies of pregnant women found the two most widely used Covid vaccines pose no risk to mothers or babies, the EU's drug regulator said on Tuesday.
-
Omicron Vaccine Could Get Approval In 3-4 Months: EU
Omicron Vaccine: Vaccines specially adapted for the new Omicron coronavirus variant could be approved in three to four months if they are needed, the head of the EU's drug regulator said on Tuesday.
-
EU Could Approve Vaccine Against New Covid Variant In 3 To 4 Months
The EU drug regulator said on Tuesday it could approve vaccines adapted to target the Omicron variant of the coronavirus within three to four months if needed, but that existing shots would continue to provide protection.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
European Union Approves Pfizer Covid Jab For 5 To 11-Year-Olds
The EU's drug regulator approved Pfizer's coronavirus jab for children aged 5 to 11 on Thursday, clearing the way for the vaccination in a cohort where the virus is rapidly spreading.
-
EU Lists Rare Spinal Condition As Johnson & Johnson Vaccine Side Effect
Europe's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of Johnson & Johnson's single-dose COVID-19 vaccine.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
EU Approval For Russia's Sputnik V Shot "Impossible This Year": Report
The EU drug regulator is unlikely to decide whether to approve Russia's Sputnik V coronavirus vaccine until at least the first quarter of 2022 because some data needed for the review is still missing, a source with knowledge of the matter said.
-
Switzerland Approves Second Covid Vaccine For Young People
Switzerland on Monday approved Moderna's Covid-19 vaccine for youngsters aged between 12 and 17 years old, weeks after EU regulators authorised the drug for the same age group.
-
EU Should OK Covishield In A Month, Says Maker Adar Poonawalla
The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list.
